Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lipidized stem cell exosome
- Development stage
- Preclinical
- Lead developer
- Yuanpin Biotech
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous, Oral, Intraperitoneal, Subcutaneous, Intranasal, Inhalation, Topical, Intradermal, Intraarticular, Intratumoral, Intrathecal
01
Overview
Lipidized stem cell exosome is a cell-free biologic therapy being developed by Yuanpin Biotech for tissue injury repair. Derived from mesenchymal stem cells (MSCs), these exosomes are extracellular vesicles that carry a cargo of bioactive molecules, including proteins, lipids, and various RNA species such as microRNAs. The lipidization process is a modification likely intended to improve the stability, bioavailability, or targeting efficiency of the exosomes. Once administered, these exosomes interact with target cells in damaged tissues to modulate inflammatory responses, promote cell proliferation, and stimulate endogenous repair mechanisms, offering a potentially safer and more standardized alternative to direct stem cell transplantation.
- Other names
- Stem Cell Exosome (Lipidized)mesenchymal stem cell exosome
Beyond the preview
Go deeper on lipidized stem cell exosome.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lipidized stem cell exosome.